Prosecution Insights
Prosecution Insights
8 pending office actions • 8 art units • 8 examiners • 0 of 8 (0%) have an AI response strategy ready • 6 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 8 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 8 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 6 (75%) |
| §102 only | 1 (12%) |
| §112 only | 1 (12%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| GOLDBERG, JEANINE ANNE | 1 | 46.0% | +40.4% |
| SALVOZA, M FRANCO G | 1 | 69.0% | +29.4% |
| GILL, RACHEL B | 1 | 65.6% | +27.7% |
| GRASER, JENNIFER E | 1 | 76.7% | +23.8% |
| HORLICK, KENNETH R | 1 | 78.9% | +15.2% |
| BAUSCH, SARAE L | 1 | 29.0% | +43.8% |
| FONTAINHAS, AURORA M | 1 | 37.5% | +48.0% |
| SKELDING, ZACHARY S | 1 | 59.9% | +41.5% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17909500 | DNA DAMAGE REPAIR GENES IN CANCER | BAUSCH, SARAE L | 15d |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18258842 | IRRADIATED WHOLE-CELL IMMUNOGENS OF ACINETOBACTER BAUMANNII | GRASER, JENNIFER E | 119d overdue |
| 17051857 | DETECTION OF AUTOANTIBODIES AGAINST DEIMINATED PROTEIN EPITOPES ASSOCIATED WITH BRAIN OXYGEN DEPRIVATION | FONTAINHAS, AURORA M | 114d overdue |
| 18427083 | PROSTATE CANCER GENE PROFILES AND METHODS OF USING THE SAME | GOLDBERG, JEANINE ANNE | 86d overdue |
| 16958539 | COMPOSITIONS AND METHODS FOR TREATING AUTOIMMUNE DISEASE | SKELDING, ZACHARY S | 73d overdue |
| 18494219 | VACCINE COMPOSITIONS OF HERPESVIRUS ENVELOPE PROTEIN COMBINATIONS TO INDUCE IMMUNE RESPONSE | GILL, RACHEL B | 38d overdue |
| 18176909 | Methods of Differentiating a Malignant Tumor from a Non-Malignant Tumor | HORLICK, KENNETH R | 4d overdue |
| 18557247 | RECOMBINANT CEDAR VIRUS CHIMERAS | SALVOZA, M FRANCO G | 9d |
| 17909500 | DNA DAMAGE REPAIR GENES IN CANCER | BAUSCH, SARAE L | 15d |
| Art Unit | Apps |
|---|---|
| 1682 | 1 |
| 1672 | 1 |
| 1671 | 1 |
| 1645 | 1 |
| 1681 | 1 |
| 1699 | 1 |
| 1675 | 1 |
| 1644 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18427083 | PROSTATE CANCER GENE PROFILES AND METHODS OF USING THE SAME | GOLDBERG, JEANINE ANNE | 1682 | §103 | Final Rejection | 86d overdue | Pending | Jan 30, 2024 |
| 18557247 | RECOMBINANT CEDAR VIRUS CHIMERAS | SALVOZA, M FRANCO G | 1672 | §103 | Non-Final OA | 9d | Pending | Oct 25, 2023 |
| 18494219 | VACCINE COMPOSITIONS OF HERPESVIRUS ENVELOPE PROTEIN COMBINATIONS TO INDUCE IMMUNE RESPONSE | GILL, RACHEL B | 1671 | §103 | Final Rejection | 38d overdue | Pending | Oct 25, 2023 |
| 18258842 | IRRADIATED WHOLE-CELL IMMUNOGENS OF ACINETOBACTER BAUMANNII | GRASER, JENNIFER E | 1645 | §103 | Non-Final OA | 119d overdue | Pending | Jun 22, 2023 |
| 18176909 | Methods of Differentiating a Malignant Tumor from a Non-Malignant Tumor | HORLICK, KENNETH R | 1681 | §102 | Non-Final OA | 4d overdue | Pending | Mar 01, 2023 |
| 17909500 | DNA DAMAGE REPAIR GENES IN CANCER | BAUSCH, SARAE L | 1699 | §103 | Final Rejection | 15d | Pending | Sep 06, 2022 |
| 17051857 | DETECTION OF AUTOANTIBODIES AGAINST DEIMINATED PROTEIN EPITOPES ASSOCIATED WITH BRAIN OXYGEN DEPRIVATION | FONTAINHAS, AURORA M | 1675 | §103 | Final Rejection | 114d overdue | Pending | Oct 30, 2020 |
| 16958539 | COMPOSITIONS AND METHODS FOR TREATING AUTOIMMUNE DISEASE | SKELDING, ZACHARY S | 1644 | §112 | Final Rejection | 73d overdue | Pending | Jun 26, 2020 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial